Company Monitoring Page for Biogen

latest headlines for company on cafepharma

RIP amyloid beta theory? Nope. Biogen partner launches a new PhIII before aducanumab's corpse turned cold
Endpoints
Fri, 03/22/19 - 11:58 am
Tags:
Biogen, Eisai, BAN2401, Alzheimer's disease, clinical trials
How Will The Failure Of Biogen's Alzheimer's Drug, Aducanumab, Impact R&D?
Forbes
Fri, 03/22/19 - 10:22 am
Tags:
Biogen, R&D, Alzheimer's disease
Where can Biogen turn after mammoth Alzheimer's blow? The M&A table, analysts say
Fierce Pharma
Thu, 03/21/19 - 12:28 pm
Tags:
Biogen, Alzheimer's disease, aducanumab, M&A
Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech
BioPharma Dive
Thu, 03/21/19 - 09:56 am
Tags:
Biogen, Eisai, Alzheimer's disease, clinical trials, aducanumab
Gene therapy progress spurs competition in biotech buyouts
Biopharma Dive
Tue, 03/19/19 - 11:41 pm
Tags:
biotech, gene therapy, M&A, Biogen, Nightstar Therapeutics, Roche, Spark Therapeutics
Partnering talks led to Biogen’s $800M Nightstar buyout as players clustered around the hot deal table for gene therapies
Endpoints
Mon, 03/18/19 - 11:48 pm
Tags:
Biogen, gene therapy, Nightstar Therapeutics, M&A
Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business
Yahoo/Reuters
Tue, 03/12/19 - 10:08 am
Tags:
Fujifilm, Biogen, M&A, Japan, biologics
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Tags:
Massachusetts, Boston, Biogen, Tecfidera, Benepali, Shire, Takeda, Vyvanse, Vertex Pharmaceuticals, Orkambi, Kalydeco, Alexion, Soliris, Strensiq, Sanofi Genzyme, Lantus, Ironwood Pharmaceuticals, Linzess
Biogen to acquire ophthalmology gene therapy play Nightstar
BioCentury
Mon, 03/4/19 - 10:37 am
Tags:
Biogen, M&A, Nightstar Therapeutics, gene therapy, ophthalmology
New insight into how Biogen's Tecfidera works may lead to better MS therapies
Fierce Biotech
Sat, 03/2/19 - 12:49 pm
Tags:
Biogen, Tecfidera, MS, multiple sclerois, R&D
FDA Accepts for Review Alkermes' and Biogen's NDA for Multiple Sclerosis Drug
CP WIre
Mon, 02/25/19 - 12:24 pm
Tags:
Alkermes, Biogen, diroximel fumarate, MS, multiple sclerosis
Mon, 02/25/19 - 10:16 am
Tags:
Alkermes, Biogen, diroximel fumarate
Biogen, BioMarin, Lilly and Bristol-Myers Could Be in Crosshairs of Acquirers
Yahoo/Guru Focus
Sun, 02/24/19 - 11:36 pm
Tags:
M&A, Merck, Biogen, Biomarin, Eli Lilly, Bristol-Myers Squibb
Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report
Fierce Pharma
Wed, 02/20/19 - 11:59 am
Tags:
M&A, oncology, neurology, Rare Diseases, Pfizer, Merck, JNJ, Biogen, Biomarin
Mylan takes step toward knocking down key patent for Biogen's top-seller
Biopharma Dive
Thu, 02/7/19 - 03:26 pm
Tags:
Mylan, Biogen, Tecfidera, patents, inter partes review
[audio+transcript] 6 Biotech Stocks to Watch Now
Motley Fool
Fri, 02/1/19 - 10:36 pm
Tags:
Biogen, Bluebird Bio, Global Blood Therapeutics, Aimmune Therapeutics, Vertex Pharmaceuticals, Sarepta Therapeutics
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
Xconomy
Wed, 01/30/19 - 11:56 am
Tags:
Roche, Alzheimer's disease, clinical trials, AC Immune, crenezumab, Biogen, aducanumab
Spinraza sales lift Biogen revenues
BioCentury
Tue, 01/29/19 - 11:15 pm
Tags:
Biogen, earnings, aducanumab, Alzheimer's disease
Pick your post-JPM buzz: Pfizer eyes Amarin, Biogen shops anyone with 'multiple' phase 3 drugs
Fierce Pharma
Sat, 01/12/19 - 11:37 am
Tags:
JPMHC 2019, M&A, Pfizer, Biogen, Amarin
Biogen stock trends up on neurology disease deals
Biopharma Dive
Tue, 01/8/19 - 11:38 pm
Tags:
Biogen, C4 Therapeutics, Skyhawk Therapeutics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.